BLACK WEEKSFlaconcini −15% · kit −10% · resto −5%con il codiceSpedizione gratuita in Germania da 200 €

Questa pagina è stata tradotta automaticamente e può contenere errori. Sei madrelingua? Saremo felici di ricevere il tuo feedback e le tue correzioni.Invia feedback

The Peptide Desk The Peptide Desk
Test Cypionate, foto del prodotto

Referto di laboratorio

PDF
Testato
Testato
Test Cypionate 250mg/ml
Laboratorio
Analiza Białek
Data
August 2026
Risultato
277.66 mg/ml measured (250 mg/ml label)
N. ordine
Password

Testato in modo indipendente, verificabile con la password direttamente presso il laboratorio.

Test Line

Test Cypionate

Test Line

Ordine

Attenzione - ricevi il flaconcino INTERO: questa misura contiene 50mg/ml · 10ml = 500mg di composto - molto più di quanto faccia pensare il valore per ml.

Prezzo unitario - Spedizione gratuita in Germania da 200 € durante le Black Weeks
  • DHL con tracciamento
  • Imballaggio discreto

4.6 su 5 su Trustpilot73 recensioni

Cercato anche come: Testosteron Cypionat · Test Cypionat

In sintesi

Test Cypionate in cifre

I dati chiave dalla nostra enciclopedia. Trascina il punto lungo la curva per vedere quanto resta dopo una dose, secondo il calcolo.

Voce completa dell'enciclopedia

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~5.5 days

Half-life ~5.5 days
After 11 days: 25 %
Day 647 %Day 1125 %Day 1711.7 %Day 282.9 %

Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 5 to 6 days, we calculate with the middle.

Half-life

about5-6days

Class
Testosterone esterlong-acting
Use
Intramuscular or subcutaneous1-2x per week
Sizes
3 sizes50mg/ml, 250mg/ml, 200mg/ml

Conoscenze

Tutto su Test Cypionate

FAQ

Domande frequenti

Fonti per ogni risposta: voce dell'enciclopedia

Hai ancora una domanda?

Scrivici, il nostro team ti aiuterà.

How long does one injection last?

In a study with 11 men the testosterone level tripled on days 2 to 5, free testosterone rose 4.5-fold. Many were above the normal range between days 2 and 7, after 13 to 14 days everything was back at baseline. With an injection every two weeks the levels therefore swung widely between high and low.

Cypionate or enanthate, what is the difference?

In practice hardly any. The esters differ by one carbon atom, once it is split off the same testosterone acts. Many studies therefore allow both, for example the clinic review on subcutaneous use and the review on haematocrit. Several cancer trials on the registry also allow cypionate or enanthate.

Is Testosterone Cypionate approved?

Yes. The ChEMBL database lists Testosterone Cypionate as an approved drug with first approval in 1978. Trials are still running on ClinicalTrials.gov, mainly on very high testosterone levels in prostate cancer. Everything here is the state of research, not a recommendation.

Does subcutaneous work too?

In a clinic review of 63 people injecting cypionate or enanthate under the skin weekly, all reached normal male levels. All 22 who had injected into the muscle before preferred subcutaneous use. Minor, transient reactions at the injection site occurred in 9 of 63.

What about haematocrit?

Testosterone stimulates the production of red blood cells. In a three-year review 66.7 percent of men on injections (cypionate or enanthate) had a haematocrit above 50 percent, 35.1 percent on pellets and 12.8 percent on gel. The men on injections were younger and had higher values at baseline. No PSA rise was seen in any group.

What is bipolar androgen therapy?

A research approach in prostate cancer that switches between very high and very low testosterone. In the randomised TRANSFORMER trial with 195 men time without progression was the same at 5.7 months with monthly testosterone and with an androgen blocker. PSA fell by at least half in 28.2 versus 25.3 percent, side effects were mostly grade 1 to 2. This is cancer research and not a pointer for personal use.

Which trials are still running?

As of 26 October 2026 eight phase 2 trials with Testosterone Cypionate are recruiting on the registry, all on prostate cancer. Two more are running without new participants, one of them on the pelvic floor in postmenopausal women.

Confronti

Come si confronta

Correlati

Prodotti correlati